Why Medical Adviser`s Group?
    Quality
    All works are performed in accordance with generally accepted international recommendations for the creation of scientific medical content. are a leading firm in providing quality and value to our customers.
    Expertise
    The expertise of our employees is confirmed by the high-profile scientific journal New England Journal of Medicine
    Development
    Our company is a finalist of the international scientific contest SPRINT Data Analysis Challenge member of our team has at least 5 years of legal experience method allows us to achieve success in problems of all levels.
    Flexibility
    We have several scientific editors in our team who specialize in various therapeutic areas and several medical writers; thus, we can replace the specialist at any time, which ensures the project consistency

    Let's have a conversation

    We will get back in touch with you
    • About us
    • Services
    • Medical writing
    • Trainings
    • Medical presentations
    • Data visualization
    Visual storytelling for medical publications

    Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial

    Addition of #elotuzumab to pomalidomide and dexamethasone led to one additional year of survival in patients with relapsed or refractory multiple #myeloma.
    https://bit.ly/3QOFf8d
    #VisualAbstract #in #hematology